Canada - English - Health Canada

pharmascience inc - sildenafil (sildenafil citrate) - tablet - 50mg - sildenafil (sildenafil citrate) 50mg - phosphodiesterase type 5 inhibitors

Canada - English - Health Canada

pharmascience inc - sildenafil (sildenafil citrate) - tablet - 100mg - sildenafil (sildenafil citrate) 100mg - phosphodiesterase type 5 inhibitors

Canada - English - Health Canada

laboratoire riva inc. - sildenafil (sildenafil citrate) - tablet - 25mg - sildenafil (sildenafil citrate) 25mg - phosphodiesterase type 5 inhibitors

Canada - English - Health Canada

laboratoire riva inc. - sildenafil (sildenafil citrate) - tablet - 50mg - sildenafil (sildenafil citrate) 50mg - phosphodiesterase type 5 inhibitors

Canada - English - Health Canada

laboratoire riva inc. - sildenafil (sildenafil citrate) - tablet - 100mg - sildenafil (sildenafil citrate) 100mg - phosphodiesterase type 5 inhibitors

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - sildenafil citrate 28.1mg equivalent to sildenafil 20mg - film coated tablet - 20 mg - active: sildenafil citrate 28.1mg equivalent to sildenafil 20mg excipient: colloidal silicon dioxide croscarmellose sodium hyprolose hypromellose macrogol 8000 magnesium stearate microcrystalline cellulose titanium dioxide - apo-sildenafil 20 mg is used to treat patients with symptom-limited pulmonary arterial hypertension (group i of the who classification of pulmonary hypertension) to improve exercise capacity. the efficacy of apo-sildenafil has not been evaluated in patients currently on bosentan therapy.

United States - English - NLM (National Library of Medicine)

camber pharmaceuticals, inc. - sildenafil citrate (unii: bw9b0ze037) (sildenafil - unii:3m7ob98y7h) - sildenafil 20 mg - adults sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (pah) (world health organization [who] group i) in adults to improve exercise ability and delay clinical worsening [see clinical studies ( 14)] . pediatric patients (1 to 17 years old) sildenafil tablets are indicated in pediatric patients 1 to 17 years old for the treatment of pulmonary arterial hypertension (pah) (who group i) to improve exercise ability and, in pediatric patients too young to perform standardized exercise testing, pulmonary hemodynamics thought to underly improvements in exercise [see clinical studies ( 14 )] .  sildenafil is contraindicated in patients with: - concomitant use of organic nitrates in any form, either regularly or intermittently, because of the greater risk of hypotension [see warnings and precautions ( 5.1)]. - concomitant use of riociguat, a guanylate cyclase stimulat

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - sildenafil citrate, quantity: 28.096 mg (equivalent: sildenafil, qty 20 mg) - tablet, film coated - excipient ingredients: magnesium stearate; croscarmellose sodium; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; hyprolose; titanium dioxide; lactose monohydrate; hypromellose; triacetin; indigo carmine aluminium lake - ? to treat patients with pulmonary arterial hypertension classified as who functional classes ii and iii, to improve exercise capacity. ? efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease. ? the efficacy of sildenafil has not been evaluated in patients currently on bosentan therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

ix biopharma pty ltd - sildenafil citrate, quantity: 70.24 mg (equivalent: sildenafil, qty 50 mg) - capsule - excipient ingredients: croscarmellose sodium; magnesium stearate; lactose monohydrate; titanium dioxide; tartrazine; sunset yellow fcf; gelatin; silicon dioxide; sodium lauryl sulfate - sildenafil is indicated for the treatment of erectile dysfunction in adult males. ,sildenafil is not indicated for use by women.

Australia - English - Department of Health (Therapeutic Goods Administration)

ix biopharma pty ltd - sildenafil citrate, quantity: 35.12 mg (equivalent: sildenafil, qty 25 mg) - capsule - excipient ingredients: croscarmellose sodium; lactose monohydrate; magnesium stearate; titanium dioxide; gelatin; silicon dioxide; sodium lauryl sulfate - sildenafil is indicated for the treatment of erectile dysfunction in adult males. ,sildenafil is not indicated for use by women.